Intravitreal Bevacizumab Injection Therapy in a Case with Choroidal Neovascular Membrane Secondary to Toxoplasmosis Retinochoroiditis
PDF
Cite
Share
Request
Case Report
VOLUME: 44 ISSUE: 3
P: 237 - 239
May 2014

Intravitreal Bevacizumab Injection Therapy in a Case with Choroidal Neovascular Membrane Secondary to Toxoplasmosis Retinochoroiditis

Turk J Ophthalmol 2014;44(3):237-239
1. Baskent Üniversitesi Tip Fakültesi, Göz Hastaliklari Anabilim Dali, Ankara, Türkiye
No information available.
No information available
Received Date: 21.03.2013
Accepted Date: 09.09.2013
PDF
Cite
Share
Request

ABSTRACT

A 57-year-old male patient presenting with visual loss in the left eye was diagnosed as choroidal neovascular membrane secondary to inactive toxoplasmosis retinochoroiditis scar. He underwent intravitreal bevacizumab injection as primary therapy. The choroidal neovascular membrane regressed partially and the initial visual acuity improved from 1/10 to 3/10. Intravitreal bevacizumab injection appears to be effective in the treatment of choroidal neovascular membrane secondary to toxoplasma retinochoroiditis.

Keywords:
Choroidal neovascular membrane, toxoplasmosis retinochoroiditis, bevacizumab